Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence?
Authors:
- 1 August 2021
- journal article
- review article
- Published by Elsevier in Cirugía Española (English Edition)
- Vol. 99 (7) , 490-499
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic EsophagusAnnals of Surgical Oncology, 2020
- Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: A systematic reviewWorld Journal of Gastrointestinal Oncology, 2019
- Locoregional and oligometastatic recurrence of esophageal cancer—what are the management strategies?Journal of Thoracic Disease, 2019
- Clinical outcome of patients with recurrent non-small cell lung cancer after trimodality therapySurgery Today, 2019
- Validity of Surgical Resection for Lymph Node or Pulmonary Recurrence of Esophageal Cancer After Definitive TreatmentWorld Journal of Surgery, 2019
- Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancerJournal of Cancer, 2019
- Predictors of Survival After Treatment of Oligometastases After EsophagectomyThe Annals of Thoracic Surgery, 2018
- Sites of metastasis and overall survival in esophageal cancer: a population-based studyCancer Management and Research, 2017
- The biology and treatment of oligometastatic cancerOncotarget, 2015
- Esophageal CancerNew England Journal of Medicine, 2003